Clinical Trial Update: Vancomycin in the Target Site Treatment of Intracranial Infection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating vancomycin at the target site for intracranial infection. The trial status is currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Infection

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: Xijing Hospital | Conditions: Vancomycin | Phase 4 | Status: UNKNOWN